Company: NIVFW
Filing Date: 2025-05-20
Form Type: F-1/A
Source: 0001213900-25-045737
Chunk: 204

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-20
Form: F-1/A
Chunk 204
---
 shares as compensation for services (Note 1)                               |     |   |  2,866,856 |   |
| Balance as at December 31, 2023                                                        |     |   |  4,331,815 |   |
| Issuance of shares through Equity Line of Credit (Note 2)                              |     |   |  1,936,236 |   |
| Issuance of shares through conversion of convertible notes                             |     |   |  2,650,000 |   |
| Decrease in subscription receivable due to reduction of work by professionals (Note 1) |     |   | (2,766,856 | ) |
| Business Combination (Note 3)                                                          |     |   | (6,028,690 | ) |
| Balance as at December 31, 2024                                                        |     | $ |    122,505 |   |

| * | -                                                                                              
 the number of shares below have been amended to apply the two reverse stock splits in February 
 2025 and in May 2025 retrospectively.                                                          |

Note 1: On January 10, 2023, the Company issued 137ordinary shares to professional party for consulting service of 10years, increasing the additional paid-in capital by $ 812,300. On December 4, 2023, the Company issued additional 345shares to DoubleClick Services Limited for consulting service of 10years, increasing the additional paid-in capital by $ 2,054,556. During 2024, the service scope and duration were reduced and the service value was adjusted accordingly pursuant to addendums to respective agreements

Note 2: On November 21, 2024, the Company
entered into a Common Shares Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC (“White
Lion”) and a related Registration Rights Agreement (the “RRA”). Pursuant to the White Lion Purchase Agreement, the Company
has the right, but not the obligation, to require White Lion to purchase, within 36 months from the Agreement effective date up to One
Hundred Million Dollars ($) in aggregate gross purchase price of newly issued Ordinary Shares, with an automatic increase to
Three Hundred Million Dollars ($) upon any substantial M&A or Material Transaction (as defined in the White Lion Purchase
Agreement) and a further option to increase to Five Hundred Million Dollars ($) after Two Hundred and Fifty Million Dollars
($) has